Aspire Biopharma Holdings, Inc.
ASBP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $4 | $11 | $497 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $37 | $0 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $108 | $35 | $600 |
| Total Curr. Assets | $148 | $46 | $1,098 |
| Property Plant & Equip (Net) | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $6,669 | $0 | $299,004 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | -$6,669 | $0 | $80 |
| Total NC Assets | $0 | $0 | $299,084 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $148 | $46 | $300,182 |
| Liabilities | – | – | – |
| Payables | $310 | $173 | $0 |
| Short-Term Debt | $1,267 | $361 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $111 | $1 | $303 |
| Total Curr. Liab. | $1,688 | $534 | $303 |
| LT Debt | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $10,813 |
| Total NC Liab. | $0 | $0 | $10,813 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 |
| Total Liabilities | $1,688 | $534 | $11,116 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $22 | $22 | $299,005 |
| Retained Earnings | -$2,777 | -$1,467 | -$9,939 |
| AOCI | $0 | $0 | $0 |
| Other Equity | $1,215 | $958 | $0 |
| Total Equity | -$1,540 | -$488 | $289,066 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $148 | $46 | $300,182 |
| Net Debt | $1,263 | $349 | -$497 |